11.03.2015 • NewsDede WillamsWackerSiltronic

Wacker “Examines Options” for Siltronic

Wacker Chemie has confirmed market rumors that it may spin off or float its semiconductor subsidiary Siltronic. The Munich-based company said management has submitted to the supervisory board "appropriate plans" for a separation of the wholly owned business.

The most favoured strategic option under consideration appears to be an initial public offering, whereby Wacker did not reveal whether it planned to sell all of its shares.

"Reshaping Siltronic's ownership structure could be beneficial for both Wacker and Siltronic," said Wacker CEO Rudolf Staudigl. With the income from a flotation, he said, the former parent company could free up funds to invest in its chemical and polysilicon operations.

Such a move also could reduce the overall capital intensity, the CEO added, while noting that Siltronic "could harness additional growth opportunities by accessing the capital markets itself."

"A further option, Wacker said, is a sale to a strategic investor. "A detailed analysis of all the possible courses of action is necessary first to see how far these goals are achievable and which path would then be appropriate," Staudigl said.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

Free Virtual Event

Sustainability in Bioprocessing
Bioprocess Forum

Sustainability in Bioprocessing

Join us to explore hot topics in sustainable bioprocessing like the industrial potential of enzymatic synthesis, innovative biocatalysis techniques, and the use of digital twins in bioprocessing.